The Cancer Letter

Inside information on cancer research and drug development

AACR creates an alliance of academic cancer centers
Foti, Willman, Weiner, and Winn tell us what the new group will seek to accomplish

In Brief

UMich Rogel receives $11.1M SPORE for radiosensitization research

Michel Sadelain, Carl June receive 2024 Breakthrough Prize in Life Sciences

Jack Cuzick receives SABCS 2023 William L. McGuire Memorial Lecture Award

VCU Massey Cancer Center changes name to VCU Massey Comprehensive Cancer Center

Johns Hopkins and AccessHope partner to expand remote access to cancer expertise for employers

MD Anderson breaks ground on new facility

Drugs & Targets

FDA approves Ojjaara as first and only treatment for myelofibrosis with anemia

FDA grants Merck sBLA priority review for Keytruda + chemoradiotherapy in cervical cancer

CHMP issues positive opinion on Keytruda in NSCLC indication

CHMP issues positive opinion on Adcetris in Hodgkin lymphoma

FDA approves Akeega for BRCA-positive metastatic castration-resistant prostate cancer

FDA approves new and updated indications for Temodar under Project Renewal

In The Clinic

Carolyn Bertozzi focused on bioorthogonal chemistry in 1996 and won the Nobel Prize in 2022
This is how her discovery got to cancer clinical trials

Conversation with The Cancer Letter
FreeTrials & Tribulations
Latest Issue
Read the latest issue
Read the latest issue
DOWNLOAD THE PDF
UPCOMING EVENTS
Oct 2023
25
JKTG Foundation Symposium: Spatial Analytics, Combination Therapies, and Metastasis
View All Events

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Login

Looking for IP Login?